spiperone has been researched along with levodopa in 56 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 36 (64.29) | 18.7374 |
| 1990's | 16 (28.57) | 18.2507 |
| 2000's | 3 (5.36) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (1.79) | 2.80 |
| Authors | Studies |
|---|---|
| Battista, AF; Fuxe, K; Goldstein, M; Lew, JY; Lieberman, A; Nakamura, S | 1 |
| Monti, JM | 1 |
| Hjälmås, K; Rubenson, A; Sillén, U | 1 |
| List, SJ; Seeman, P | 1 |
| Bannister, R; Mackay, AV; Quik, M; Spokes, EG | 1 |
| Heffner, TG; Stricker, EM; Zigmond, MJ | 2 |
| Mora, F; Rolls, ET; Sanguinetti, AM; Sweeney, KF | 1 |
| Sickles, AE; Stehouwer, DJ; Van Hartesveldt, C | 1 |
| Ahlskog, JE; Carmichael, SW; Kelly, PJ; Nelson, A; Okazaki, H; Richelson, E; Stoddard, SL; Tyce, GM; van Heerden, JA | 1 |
| Inoue, O; Itoh, T; Långström, B; Suhara, T; Tohgi, H; Tsukada, H; Yamasaki, T; Yonezawa, H | 1 |
| Deng, MH; Lopez G-Coviella, I; Lynch, HJ; Wurtman, RJ | 1 |
| Bédard, PJ; Di Paolo, T; Gagnon, C | 1 |
| Långström, B | 1 |
| Bédard, PJ; Di Paolo, T; Rouillard, C | 1 |
| Cassel, G; Persson, SA; Sellström, A | 1 |
| Flauto, C; Groppetti, A; Parati, E; Parenti, M; Vescovi, A | 1 |
| Flauto, C; Groppetti, A; Parati, E; Parenti, M; Rusconi, L; Vescovi, A | 1 |
| Agid, Y; Bonnet, AM; Javoy-Agid, F; Ruberg, M | 1 |
| Boyce, S; Clarke, CE; Crossman, AR; Robertson, RG; Sambrook, MA | 1 |
| Bondarenko, NA; Gorantcheva, J; Nikolova, M; Tyutyulkova, N; Valdman, AV | 1 |
| Bianchi, M; Burlina, AP; Fasolato, C; Galzigna, L; Previero, A | 1 |
| Frackowiak, RS; Leenders, KL; Marsden, CD; Quinn, N | 1 |
| Bédard, PJ; Dipaolo, T; Falardeau, P; Rouillard, C | 1 |
| Bédard, PJ; Boucher, R; Di Paolo, T; Falardeau, P | 1 |
| De Jesus, OT; Dinerstein, RJ; Friedman, AM; Van Moffaert, GJ | 1 |
| McGrath, PC; Neifeld, JP | 1 |
| Concas, A; Porceddu, ML | 1 |
| Fayle, P; Jackson, DM; Jenkins, OF; Lafferty, PA | 1 |
| Koskinen, V; Lönnberg, P; Rinne, UK | 1 |
| Agnati, LF; Benefenati, F; Calza, L; Farabegoli, C; Fuxe, K; Goldstein, M; Zini, I | 1 |
| Achilli, G; Algeri, S; Cimino, M; Lipartiti, M; Perego, C; Ponzio, F; Vantini, G | 1 |
| Deupree, JD; Murrin, LC; Pfeiffer, RF; Schneider, MB | 1 |
| Bondiolotti, GP; Cocchi, D; Locatelli, V; Müller, EE; Parati, EA; Parenti, M; Penalva, A; Picotti, GB | 1 |
| Hens, L; Laduron, PM; Laterre, CE; Maloteaux, JM | 1 |
| Agid, Y; Bokobza, B; Javoy-Agid, F; Ruberg, M; Scatton, B | 1 |
| Bannet, J; Belmaker, RH; Globus, M; Lerer, B | 1 |
| Friedhoff, AJ; Friedman, E; Rosengarten, H | 1 |
| Fahn, S; Jackson, V; Jiang, D; Reches, A; Wagner, HR | 1 |
| Duvoisin, RC; Heikkila, RE; Shapiro, BS | 1 |
| Houlihan, G; Miller, ST; Nerder, LJ; Papavasiliou, PS; Rao, SN; Stevens, JM; Thal, LJ | 1 |
| Suga, M | 1 |
| Arnold, G; Bandmann, O; Bondy, B; Gasser, T; Oertel, WH; Poewe, W; Schwarz, J; Trenkwalder, C; Wagner, M | 1 |
| Anderson, JL | 1 |
| Kanazawa, I; Kimura, M; Murata, M | 1 |
| Alexander, GM; Brainard, L; Gordon, SW; Grothusen, JR; Schwartzman, RJ | 1 |
| Kołodziejczyk, K; Maj, J; Rogóz, Z; Skuza, G | 1 |
| McCrea, AE; Stehouwer, DJ; Van Hartesveldt, C | 1 |
| Bjurling, P; Fasth, KJ; Hartvig, P; Långström, B; Tedroff, J; Torstenson, R; Watanabe, Y | 1 |
| Haida, M; Kozuma, R; Shinohara, Y; Takagi, S; Takahashi, W; Yoshii, F | 1 |
| Borbely, K; Brooks, RA; Burns, RS; Cumming, P; Di Chiro, G; Gjedde, A; Wong, DF | 1 |
| Kameda, K; Koyama, T; Kusumi, I; Miura, J; Suzuki, K; Tanaka, T | 1 |
| Hideyama, T; Kwak, S; Momose, T; Shimizu, J; Tsuji, S | 1 |
| Chen, J; Ma, L; Wang, F; Zhang, H; Zhen, X | 1 |
| Butler, IJ; Clement-Cormier, YC; Seifert, WE; Wilner, KD | 1 |
| Ashby, R; Karouta, C; Morgan, I; Thomson, K | 1 |
2 review(s) available for spiperone and levodopa
| Article | Year |
|---|---|
Design of molecules labeled with beta+ emitters for use in multitracer investigations using positron emission tomography.
Topics: Beta Particles; Humans; Isotope Labeling; Levodopa; Methionine; Neurotransmitter Agents; Nomifensine; Raclopride; Salicylamides; Spiperone; Tomography, Emission-Computed | 1990 |
MPTP-induced parkinsonism in the monkey: neurochemical pathology, complications of treatment and pathophysiological mechanisms.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Brain; Deoxyglucose; Haplorhini; Humans; Levodopa; Movement Disorders; Parkinson Disease, Secondary; Pyridines; Receptors, Dopamine; Spiperone | 1987 |
1 trial(s) available for spiperone and levodopa
| Article | Year |
|---|---|
3H-spiperone binding to lymphocytes fails in the differential diagnosis of de novo Parkinson syndromes.
Topics: Adult; Aged; Butaclamol; Diagnosis, Differential; Double-Blind Method; Female; Humans; Kinetics; Levodopa; Lymphocytes; Male; Middle Aged; Parkinson Disease; Prospective Studies; Spiperone; Tremor | 1993 |
53 other study(ies) available for spiperone and levodopa
| Article | Year |
|---|---|
Dopaminephilic properties of ergot alkaloids.
Topics: Acetonitriles; Animals; Bromocriptine; Corpus Striatum; Ergolines; Ergot Alkaloids; Haplorhini; Humans; Levodopa; Parkinson Disease; Receptors, Dopamine; Spiperone; Substantia Nigra; Synaptosomes; Tremor; Tyrosine 3-Monooxygenase | 1978 |
The effects of neuroleptics with central dopamine and noradrenaline receptor blocking properties in the L-DOPA and (+)-amphetamine-induced waking EEG in the rat.
Topics: Animals; Antipsychotic Agents; Dextroamphetamine; Electroencephalography; Haloperidol; Levodopa; Male; Norepinephrine; Pimozide; Rats; Receptors, Adrenergic; Receptors, Dopamine; Sleep; Spiperone; Wakefulness | 1979 |
Evidence for a central monoaminergic influence on urinary bladder control mechanism.
Topics: 5-Hydroxytryptophan; Animals; Benserazide; Brain; Carbidopa; Catecholamines; Dopamine; Levodopa; Male; Norepinephrine; Parasympathetic Nervous System; Pressure; Rats; Spiperone; Urinary Bladder; Urodynamics | 1979 |
Dopamine agonists reverse the elevated 3H-neuroleptic binding in neuroleptic-pretreated rats.
Topics: Animals; Apomorphine; Bromocriptine; Carbidopa; Corpus Striatum; Dyskinesia, Drug-Induced; Haloperidol; Levodopa; Male; Radioligand Assay; Rats; Receptors, Dopamine; Receptors, Drug; Spiperone | 1979 |
Alterations in [3H]spiperone binding in human caudate nucleus, substantia nigra and frontal cortex in the Shy-Drager syndrome and Parkinson's disease.
Topics: Binding Sites; Butyrophenones; Caudate Nucleus; Cerebral Cortex; Frontal Lobe; Humans; Levodopa; Muscular Atrophy; Neuromuscular Diseases; Parkinson Disease; Receptors, Dopamine; Spiperone; Substantia Nigra; Syndrome | 1979 |
Effects of dopaminergic agonists and antagonists of feeding in intact and 6-hydroxydopamine-treated rats.
Topics: Animals; Apomorphine; Benztropine; Bis(4-Methyl-1-Homopiperazinylthiocarbonyl)disulfide; Brain; Catecholamines; Cocaine; Dextroamphetamine; Dopamine; Dopamine Antagonists; Eating; Hydroxydopamines; Levodopa; Male; Methylphenidate; Methyltyrosines; Motor Activity; Rats; Spiperone; Telencephalon | 1977 |
Spontaneous firing rate of neurones in the prefrontal cortex of the rat: evidence for a dopaminergic inhibition.
Topics: Action Potentials; Animals; Apomorphine; Cerebral Cortex; Dextroamphetamine; Dopamine; Dose-Response Relationship, Drug; Frontal Lobe; Levodopa; Male; Neural Inhibition; Neurons; Rats; Receptors, Dopamine; Spiperone | 1976 |
Dopamine D1 and D2 antagonists block L-dopa-elicited air-stepping in neonatal rats.
Topics: Animals; Animals, Newborn; Benzazepines; Dopamine Antagonists; Female; Levodopa; Male; Motor Activity; Rats; Rats, Inbred Strains; Receptors, Dopamine D1; Receptors, Dopamine D2; Spiperone; Stereotyped Behavior; Time Factors | 1992 |
Reduced D2 dopamine and muscarinic cholinergic receptor densities in caudate specimens from fluctuating parkinsonian patients.
Topics: Adult; Brain Tissue Transplantation; Bromocriptine; Caudate Nucleus; Down-Regulation; Humans; Levodopa; Middle Aged; Parkinson Disease; Pergolide; Quinuclidinyl Benzilate; Receptors, Cholinergic; Receptors, Dopamine; Receptors, Dopamine D2; Receptors, Muscarinic; Receptors, Neurotransmitter; Spiperone | 1991 |
Effect of L-dopa and reserpine on in vivo binding of (3H)-SCH 23390 and (3H)-N-methylspiperone.
Topics: Animals; Benzazepines; Dopamine Agents; Levodopa; Male; Mice; Reserpine; Spiperone; Tritium | 1991 |
Melatonin and its precursors in Y79 human retinoblastoma cells: effect of sodium butyrate.
Topics: 5-Hydroxytryptophan; Analysis of Variance; Butyrates; Butyric Acid; Cell Line; Colforsin; Dopamine; Eye Neoplasms; Humans; Kinetics; Levodopa; Melatonin; Retinoblastoma; Serotonin; Spiperone | 1991 |
Effect of chronic treatment of MPTP monkeys with dopamine D-1 and/or D-2 receptor agonists.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Autoradiography; Brain; Bromocriptine; Carbidopa; Catecholamines; Dopamine Agents; Female; Levodopa; Macaca fascicularis; Receptors, Dopamine; Spiperone | 1990 |
Effects of chronic treatment of MPTP monkeys with bromocriptine alone or in combination with SKF 38393.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; 3,4-Dihydroxyphenylacetic Acid; Animals; Antiparkinson Agents; Brain; Brain Chemistry; Bromocriptine; Dopamine; Female; Homovanillic Acid; Kinetics; Levodopa; Macaca fascicularis; Motor Activity; MPTP Poisoning; Parkinson Disease, Secondary; Receptors, Dopamine; Spiperone | 1990 |
Acute cyanide intoxication and central transmitter systems.
Topics: 3,4-Dihydroxyphenylacetic Acid; Amino Acids; Animals; Apomorphine; Brain; Cyanides; Cyclic GMP; Dopamine; gamma-Aminobutyric Acid; Homovanillic Acid; Levodopa; Male; Neurotransmitter Agents; Norepinephrine; Rats; Rats, Inbred Strains; Spiperone | 1985 |
Differential effect of repeated treatment with L-dopa on dopamine-D1 or -D2 receptors.
Topics: Adenylyl Cyclases; Animals; Antipsychotic Agents; Apomorphine; Benzazepines; Hydroxydopamines; Levodopa; Male; Oxidopamine; Rats; Rats, Inbred Strains; Receptors, Dopamine; Spiperone | 1986 |
Dopamine receptor changes in response to prolonged treatment with L-dopa.
Topics: Adenylyl Cyclases; Animals; Apomorphine; Benzazepines; Carbidopa; Corpus Striatum; Dopamine; Hydroxydopamines; Levodopa; Male; Oxidopamine; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Dopamine D1; Spiperone; Stereotyped Behavior; Substantia Nigra; Sulpiride | 1986 |
Pathophysiology of L-dopa-induced abnormal involuntary movements.
Topics: Brain; Corpus Striatum; Dopamine; Dyskinesia, Drug-Induced; Humans; Levodopa; Neural Pathways; Parkinson Disease; Receptors, Dopamine; Spiperone; Substance Withdrawal Syndrome; Substantia Nigra; Synapses; Synaptic Transmission | 1985 |
Effect of some benzamide derivatives on stress-induced behavior and striatum dopamine receptors.
Topics: Animals; Behavior, Animal; Benzamides; Corpus Striatum; Immobilization; Levodopa; Male; Morpholines; Motor Activity; Rats; Rats, Inbred Strains; Receptors, Dopamine; Spiperone; Stress, Psychological; Tiapamil Hydrochloride | 1988 |
Dopamine-depleting activity of L-3,4-(dioxyphenylacetyl)-phenylalanine.
Topics: Animals; Binding, Competitive; Blood-Brain Barrier; Brain; Dopamine; Enzyme Activation; Levodopa; Male; Mice; Mice, Inbred C57BL; Mitochondria; Monoamine Oxidase; Receptors, Dopamine; Spiperone; Synaptosomes | 1988 |
Brain dopaminergic system studied in patients with dystonia using positron emission tomography.
Topics: Adult; Brain; Dopamine; Dystonia; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Spiperone; Tomography, Emission-Computed; Torticollis | 1988 |
Behavioral and biochemical evidence for a different effect of repeated administration of L-dopa and bromocriptine on denervated versus non-denervated striatal dopamine receptors.
Topics: Animals; Behavior, Animal; Benserazide; Bromocriptine; Corpus Striatum; Denervation; Female; In Vitro Techniques; Levodopa; Rats; Receptors, Dopamine; Spiperone | 1987 |
Chronic treatment with L-DOPA, but not bromocriptine induces dyskinesia in MPTP-parkinsonian monkeys. Correlation with [3H]spiperone binding.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Binding Sites; Bromocriptine; Butyrophenones; Female; Kinetics; Levodopa; Macaca fascicularis; Movement Disorders; Parkinson Disease, Secondary; Pyridines; Spiperone; Time Factors | 1986 |
Exogenous l-dopa alters spiroperidol binding, in vivo, in the mouse striatum.
Topics: alpha-Methyltyrosine; Animals; Benserazide; Biological Transport; Butyrophenones; Cerebellum; Corpus Striatum; Dopamine; Dose-Response Relationship, Drug; Levodopa; Methyltyrosines; Mice; Receptors, Dopamine; Reserpine; Spiperone | 1986 |
Inhibition of human neuroblastoma by dopamine antagonists.
Topics: Animals; Cell Division; Cell Line; Domperidone; Dopamine; Dopamine Antagonists; Female; Humans; Levodopa; Mice; Mice, Nude; Neuroblastoma; Pimozide; Receptors, Dopamine; Spiperone | 1985 |
Partial protection by CDP-choline against kainic acid-induced lesion in the rat caudate nucleus.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Caudate Nucleus; Choline; Cytidine Diphosphate Choline; Dopamine; Kainic Acid; Levodopa; Male; Rats; Rats, Inbred Strains; Receptors, Dopamine; Spiperone; Time Factors | 1985 |
The effect of dopamine receptor agonist treatment on haloperidol-induced supersensitivity in mice.
Topics: alpha-Methyltyrosine; Animals; Apomorphine; Corpus Striatum; Dextroamphetamine; Haloperidol; Levodopa; Male; Methyltyrosines; Mice; Motor Activity; Receptors, Dopamine; Reserpine; Spiperone | 1985 |
Dopamine receptors in the Parkinsonian brain.
Topics: Aged; Antipsychotic Agents; Brain; Caudate Nucleus; Female; Humans; Kinetics; Levodopa; Male; Parkinson Disease; Postmortem Changes; Putamen; Receptors, Dopamine; Spiperone | 1981 |
Chronic treatment with 1-dopa plus carbidopa in hemitransected rats: preferential effects at intact dopamine synapses leading to behavioural signs of dopamine receptor supersensitivity.
Topics: Animals; Behavior, Animal; Carbidopa; Corpus Striatum; Diencephalon; Fluorescent Antibody Technique; Levodopa; Male; Nerve Endings; Rats; Rats, Inbred Strains; Receptors, Dopamine; Rotation; Spiperone; Substantia Nigra; Synapses; Tyrosine 3-Monooxygenase | 1983 |
In vivo and in vitro evidence of dopaminergic system down regulation induced by chronic L-DOPA.
Topics: Animals; Apomorphine; Benserazide; Binding Sites; Cell Membrane; Corpus Striatum; Dopamine; Hydrazines; Levodopa; Male; Rats; Rats, Inbred Strains; Receptors, Dopamine; Spiperone; Tetrahydronaphthalenes; Tyrosine 3-Monooxygenase | 1984 |
Dopamine receptors: effects of chronic L-dopa and bromocriptine treatment in an animal model of Parkinson's disease.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Bromocriptine; Corpus Striatum; Disease Models, Animal; Dopamine; Humans; Hydroxydopamines; Kinetics; Levodopa; Male; Membranes; Oxidopamine; Parkinson Disease; Rats; Rats, Inbred Strains; Receptors, Dopamine; Spiperone; Stereotyped Behavior; Substantia Nigra | 1984 |
Mechanisms involved in the prolactin-releasing effect of benserazide.
Topics: Animals; Benserazide; Binding, Competitive; Dopamine; Female; Hydrazines; In Vitro Techniques; Levodopa; Male; Median Eminence; Pituitary Gland, Anterior; Prolactin; Rats; Rats, Inbred Strains; Receptors, Dopamine; Spiperone | 1984 |
Failure of a peripheral dopaminergic marker in Parkinson's disease.
Topics: Adult; Aged; Humans; Levodopa; Lymphocytes; Middle Aged; Parkinson Disease; Receptors, Dopamine; Spiperone; Tritium | 1983 |
[3H]spiperone binding, dopamine and HVA concentrations in Parkinson's disease and supranuclear palsy.
Topics: Aged; Brain; Butyrophenones; Caudate Nucleus; Dopamine; Homovanillic Acid; Humans; Levodopa; Nucleus Accumbens; Paralysis; Parkinson Disease; Phenylacetates; Putamen; Receptors, Dopamine; Spiperone; Substantia Nigra | 1984 |
The effect of chronic bromocriptine and L-dopa on spiperone binding and apomorphine-induced stereotypy.
Topics: Animals; Apomorphine; Bromocriptine; Butyrophenones; Corpus Striatum; Dose-Response Relationship, Drug; Haloperidol; Humans; Levodopa; Male; Muridae; Receptors, Dopamine; Spiperone; Stereotyped Behavior | 1982 |
Sensitive periods for the effect of haloperidol on development of striatal dopamine receptors.
Topics: alpha-Methyltyrosine; Animals; Corpus Striatum; Dopamine; Female; Gestational Age; Haloperidol; Levodopa; Methyltyrosines; Pregnancy; Rats; Receptors, Dopamine; Spiperone | 1983 |
The effect of chronic L-dopa administration on supersensitive pre- and postsynaptic dopaminergic receptors in rat brain.
Topics: Animals; Brain; Haloperidol; Hydrazines; Levodopa; Male; Rats; Rats, Inbred Strains; Receptors, Dopamine; Spiperone | 1982 |
The effect of altered dopaminergic activity on food intake in the rat: evidence for an optimal level of dopaminergic activity for behavior.
Topics: Amphetamine; Amphetamines; Animals; Apomorphine; Brain; Cocaine; Dextroamphetamine; Dopamine; Feeding Behavior; Haloperidol; Levodopa; Methylphenidate; Rats; Spiperone | 1980 |
The relationship between loss of dopamine nerve terminals, striatal [3H]spiroperidol binding and rotational behavior in unilaterally 6-hydroxydopamine-lesioned rats.
Topics: Animals; Butyrophenones; Corpus Striatum; Dopamine; Female; Functional Laterality; Hydroxydopamines; Levodopa; Movement; Neurons; Rats; Receptors, Dopamine; Spiperone | 1981 |
Age-related motor and catecholamine alterations in mice on levodopa supplemented diet.
Topics: Aging; Animals; Brain Chemistry; Catecholamines; Diet; Levodopa; Male; Mice; Motor Activity; Quinuclidinyl Benzilate; Receptors, Dopamine; Receptors, Muscarinic; Spiperone | 1981 |
Effect of long-term L-dopa administration on the dopaminergic and cholinergic (muscarinic) receptors of striatum in 6-hydroxydopamine lesioned rats.
Topics: Animals; Corpus Striatum; Hydroxydopamines; Levodopa; Male; Quinuclidinyl Benzilate; Rats; Receptors, Cholinergic; Receptors, Dopamine; Receptors, Muscarinic; Spiperone | 1980 |
A rapid and accurate method to realign PET scans utilizing image edge information.
Topics: Acetates; Animals; Brain; Carbon Radioisotopes; Cerebrovascular Circulation; Dopamine Antagonists; Heart; Humans; Image Processing, Computer-Assisted; Levodopa; Oxygen Radioisotopes; Spiperone; Swine; Tomography, Emission-Computed; Water | 1995 |
Roles of dopamine and its receptors in generation of choreic movements.
Topics: Afferent Pathways; Animals; Brain Mapping; Cerebral Cortex; Choline O-Acetyltransferase; Chorea; Corpus Striatum; Disease Models, Animal; Dopamine; gamma-Aminobutyric Acid; Glutamates; Glutamic Acid; Kainic Acid; Levodopa; Macaca; Neurons; Receptors, Dopamine; Receptors, Dopamine D2; Spiperone; Substantia Nigra; Synapses; Tyrosine 3-Monooxygenase | 1993 |
Changes in brain dopamine receptors in MPTP parkinsonian monkeys following L-dopa treatment.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Autoradiography; Benzazepines; Brain; Levodopa; Macaca fascicularis; Parkinson Disease, Secondary; Receptors, Dopamine D1; Receptors, Dopamine D2; Spiperone | 1993 |
The behavioural effects of pramipexole, a novel dopamine receptor agonist.
Topics: Animals; Antiparkinson Agents; Benzazepines; Benzothiazoles; Body Temperature; Catalepsy; Clozapine; Dopamine Agents; Dopamine Agonists; Dopamine Antagonists; Dose-Response Relationship, Drug; Drug Interactions; Dyskinesia, Drug-Induced; Haloperidol; Injections, Subcutaneous; Levodopa; Male; Mice; Motor Activity; Pramipexole; Rats; Rats, Wistar; Receptors, Dopamine D2; Receptors, Dopamine D3; Spiperone; Stereotyped Behavior; Sulpiride; Thiazoles | 1997 |
Dopamine D1 and D2 antagonists block L-DOPA-induced air-stepping in decerebrate neonatal rats.
Topics: Animals; Animals, Newborn; Benzazepines; Decerebrate State; Dopamine D2 Receptor Antagonists; Levodopa; Motor Activity; Rats; Receptors, Dopamine D1; Spiperone; Stereotyped Behavior | 1997 |
Amphetamine effects on dopamine release and synthesis rate studied in the Rhesus monkey brain by positron emission tomography.
Topics: Amphetamine; Animals; Brain; Cerebrovascular Circulation; Decarboxylation; Dopamine; Dopamine Agents; Dopamine Agonists; Dopamine Antagonists; Female; Levodopa; Macaca mulatta; Raclopride; Salicylamides; Spiperone; Tomography, Emission-Computed | 1997 |
Magnetic resonance imaging and 11C-N-methylspiperone/positron emission tomography studies in a patient with the interval form of carbon monoxide poisoning.
Topics: Basal Ganglia; Bromocriptine; Carbon Monoxide Poisoning; Carbon Radioisotopes; Caudate Nucleus; Cerebral Hemorrhage; Combined Modality Therapy; Convalescence; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Globus Pallidus; Humans; Hyperbaric Oxygenation; Levodopa; Magnetic Resonance Imaging; Male; Middle Aged; Necrosis; Nerve Tissue Proteins; Parkinson Disease, Secondary; Psychomotor Performance; Putamen; Receptors, Dopamine D2; Spiperone; Tomography, Emission-Computed | 1998 |
NMSP binding to dopamine and serotonin receptors in MPTP-induced parkinsonism: relation to dopa therapy.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Adult; Antiparkinson Agents; Binding Sites; Cerebellum; Dopamine Antagonists; Humans; Levodopa; Male; Models, Chemical; Occupational Diseases; Parkinson Disease, Secondary; Putamen; Receptors, Dopamine; Receptors, Serotonin; Severity of Illness Index; Spiperone; Tomography, Emission-Computed | 1999 |
Effects of lithium on dopamine D2 receptor expression in the rat brain striatum.
Topics: Animals; Antidepressive Agents; Dopamine; Dopamine Agents; Dopamine Antagonists; Drug Interactions; Gene Expression Regulation; Hyperkinesis; Levodopa; Lithium Carbonate; Male; Methamphetamine; Neostriatum; Neurons; Radioligand Assay; Rats; Rats, Wistar; Receptors, Dopamine D2; RNA, Messenger; Spiperone; Transcription, Genetic; Tritium | 2001 |
A positron emission tomography study on the role of nigral lesions in parkinsonism in patients with amyotrophic lateral sclerosis.
Topics: Aged; Amyotrophic Lateral Sclerosis; Cerebrovascular Circulation; Female; Humans; Levodopa; Male; Middle Aged; Motor Neuron Disease; Parkinson Disease; Positron-Emission Tomography; Radiopharmaceuticals; Spiperone; Substantia Nigra; Tomography, Emission-Computed, Single-Photon | 2006 |
Chronic SKF83959 induced less severe dyskinesia and attenuated L-DOPA-induced dyskinesia in 6-OHDA-lesioned rat model of Parkinson's disease.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Analysis of Variance; Animals; Disease Models, Animal; Dopamine Agonists; Dopamine Antagonists; Drug Administration Schedule; Drug Interactions; Dyskinesia, Drug-Induced; Levodopa; Male; Movement; Oxidopamine; Parkinson Disease; Proto-Oncogene Proteins c-fos; Rats; Rats, Sprague-Dawley; Serotonin Antagonists; Spiperone; Sympatholytics; Time Factors | 2007 |
Biochemical alterations of dopamine receptor responses following chronic L-dopa therapy.
Topics: Adenylyl Cyclases; Animals; Carbidopa; Corpus Striatum; Dopamine; Drug Interactions; Homovanillic Acid; Hydroxyindoleacetic Acid; Levodopa; Male; Methoxyhydroxyphenylglycol; Rats; Rats, Sprague-Dawley; Receptors, Dopamine; Spiperone | 1980 |
Levodopa inhibits the development of lens-induced myopia in chicks.
Topics: Animals; Benzazepines; Chickens; Disease Models, Animal; Dose-Response Relationship, Drug; Intravitreal Injections; Lenses; Levodopa; Male; Myopia; Ophthalmic Solutions; Receptors, Dopamine D2; Spiperone | 2020 |